FUS affects circular RNA expression in murine embryonic stem cell-derived motor neurons by Errichelli, Lorenzo et al.
ARTICLE
Received 24 Jun 2016 | Accepted 26 Jan 2017 | Published 30 Mar 2017
FUS affects circular RNA expression in murine
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The RNA-binding protein FUS participates in several RNA biosynthetic processes and has
been linked to the pathogenesis of amyotrophic lateral sclerosis (ALS) and frontotemporal
dementia. Here we report that FUS controls back-splicing reactions leading to circular RNA
(circRNA) production. We identified circRNAs expressed in in vitro-derived mouse motor
neurons (MNs) and determined that the production of a considerable number of these
circRNAs is regulated by FUS. Using RNAi and overexpression of wild-type and ALS-asso-
ciated FUS mutants, we directly correlate the modulation of circRNA biogenesis with
alteration of FUS nuclear levels and with putative toxic gain of function activities. We also
demonstrate that FUS regulates circRNA biogenesis by binding the introns flanking the
back-splicing junctions and that this control can be reproduced with artificial constructs. Most
circRNAs are conserved in humans and specific ones are deregulated in human-induced
pluripotent stem cell-derived MNs carrying the FUSP525L mutation associated with ALS.
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A
new class of covalently closed circular RNA molecules
(circRNAs) has recently become the object of intensive
study. First described as rare events1–3, recent studies
have demonstrated that circRNAs are commonly produced by
thousands of genes from Archaea to mammals4–6. Interestingly,
in higher eukaryotes they are highly expressed in neuronal tissues
and enriched at synapses, suggesting a specific involvement
in neuronal processes7,8. Moreover, circRNAs are more abundant
than their host gene linear mRNA isoforms in the neuropil
and dendrites, suggesting that they may regulate synaptic
function and neuronal plasticity8.
So far, very little is known about their function: some can act as
sponges for microRNAs and proteins9–11 or can compete with
linear RNA production regulating the accumulation of full-length
mRNA12. CircRNAs also regulate transcription of their parental
genes by association with the RNA polymerase II machinery13.
Notably, emerging data point to a potential role of circRNAs in
human diseases14,15, with clear evidence of tumor-promoting
properties in in vivo models16. In the nervous system, the best-
studied circRNA, CDR1, was found expressed in neocortical and
hippocampal neurons and downregulated in Alzheimer disease17.
Through its ability to sponge miR-7 (refs 9,10), it could play
a crucial role in nervous system diseases deregulating targets with
important function17,18.
CircRNAs originate from a back-splicing reaction in which
a downstream 50 splice site interacts with an upstream 30 splice
site, leading to the formation of a covalently closed circRNA19.
The mechanisms underlying these events are not fully under-
stood; however, in mammals it has been shown that compleme-
ntarity between inverted sequences inside flanking introns3,20–22
and the activity of RNA-binding proteins (RBPs)12,23 enhance the
juxtaposition of the splice sites involved in the back-splicing
reaction. Muscleblind, a splicing factor derived from the
Mbl gene, was the first example of an RBP controlling the
levels of the circRNA derived from its second exon by binding
both flanking introns12. Afterwards, Quaking (QKI), a splicing
factor that promotes myelination and oligodendrocyte
differentiation24,25, was also described as a circRNA regulator23.
Finally, many hnRNPs as well as SR proteins are involved in
circRNA production in flies26.
The RBP FUS has a well-characterized role in splicing
regulation27 with several splicing factors identified as FUS
interactors28–31. FUS functions are particularly interesting since
several mutations have been causally linked to amyotrophic
lateral sclerosis (ALS)32,33. Most ALS-linked FUS mutations
cluster in the C-terminus of the protein in or near the nuclear
localization signal. This leads to the mislocalization of the protein
to the cytoplasm, with decrease of FUS levels in the nucleus and
formation of abnormal cytoplasmic aggregates32–34. Aberrant
RNA metabolism due to FUS mutations by gain- and/or loss-of-
function has been proposed as a key mechanisms in the
pathogenesis of ALS and frontotemporal dementia35; moreover,
deregulation of splicing has been linked to several neurological
diseases32,36,37.
In this study, we identify circRNAs expressed in in vitro-
derived motor neurons (MNs) and we analyse whether FUS may
be involved in the control of back-splicing events leading to
circRNA formation. We characterize several circRNAs that are
affected by FUS depletion and by FUS mutations associated with
familial forms of ALS. Notably, for selected circRNAs, we
demonstrate the enrichment of FUS binding on circularizing
exon–intron regions by cross-linking immunoprecipitation
(CLIP) and the direct role of the protein in regulating
back-splicing. Finally, most of these circRNAs are expressed
in induced pluripotent stem cells (iPSCs)-derived human
MNs and two of them undergo similar FUS-dependent regulation
in ALS-associated FUSP525L genetic background. Altogether,
our data suggest a possible conserved function of this novel
class of transcripts and provide an interesting link with the
ALS pathology.
Results
Identification of circRNAs in mESC-derived MNs. Mouse
embryonic stem cells (mESCs), derived from wild-type (FUSþ /þ )
or knock out (FUS / )38 FUS mice and expressing a green
fluorescent protein (GFP) reporter under the control of the
MN-specific Hb9 promoter (Hb9::GFP transgene)39, were
differentiated into bona fide MNs according to Wichterle et al.40
(Supplementary Fig. 1a). In agreement with this procedure, Pax6
and Olig2 transcription factors, responsible for establishing
MN progenitors, were found in the Hb9::GFP cells while genes
required for consolidation of MN identity (Hb9) and for
development (Islet-1) and function (ChAT) of spinal MNs were
highly enriched in Hb9::GFPþ cells. As expected, the markers for
astrocytes (Gfap) and oligodendrocytes (Pdgfr-a) were almost
undetectable in both cell populations as well as the V1, V2
(Bhlhe22) and V3 (Sim1) interneuron markers (Supplementary
Fig. 1b,c). Total RNA from purified GFPþ -FUSþ /þ and GFPþ -
FUS / MNs was sequenced by ribo-Zero Next-Generation
Sequencing from three biological replicates. A dedicated pipeline
for in silico circRNA detection was then applied (find_circ)10 to
identify circRNAs and to evaluate their expression levels. Briefly,
reads mapping to ribosomal and other abundant non-coding RNAs
were discarded (see Methods section), as were reads mapping
contiguously to the reference genome, and the unmapped reads
were used as input for circRNA identification (Fig. 1a). Since no
reference transcriptome is used in the procedure, the back-splicing
sites of the identified circRNAs do not necessarily coincide
with annotated splice sites. The number of reads mapping
on back-splicing and on corresponding linear-splicing junctions
was computed. Three thousand nine hundred and eighty circRNAs
were identified, having at least two unique reads mapping on
their back-splicing junction in at least one sample (Table 1).
This number is similar to that obtained from sequencing
experiments previously performed on other neuronal samples7,
confirming the high abundance of circRNAs in neuronal tissues,
now also including in vitro mESC-derived MNs. We identified
3,894 circRNAs within the body of 2,097 known genes, many
hosting more than one circRNA. As shown in Fig. 1b, the vast
majority of these genes are protein-coding. Analysing
the localization of circRNAs within the body of protein-coding
transcripts (Supplementary Fig. 1d), we found that most of
them are fully included in the coding region with a proportion
spanning across the 50 untranslated region higher than expected
(22%, P value for chi-squared test¼ 1.15e 28) (Fig. 1c and
Supplementary Fig. 1e).
CircRNA expression is modulated in FUS / MNs. To retain
only those circRNAs that are robustly expressed (two or more
unique reads in at least three samples), the identified candidates
were then filtered to generate a list of 1,153 circRNAs from a total
of 785 hosting genes (Supplementary Data 1). Using this list, we
performed a differential expression analysis in FUS / versus
FUSþ /þ conditions (see Methods section), and we plotted the log2
fold change values of the 1,153 circRNAs against those of their
cognate linear transcripts, whose expression was quantified using
the reads assigned to the linear junctions (Fig. 1d). In FUS /
condition, we found a general reduction in the expression of
circRNAs (P value for one-sample t-test¼ 3.16e 24), while the
distribution of fold changes of their cognate linear RNAs is
centered at 0 (P value for one-sample t-test¼ 0.27) (Fig. 1d).
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The differential expression analysis revealed that, in
the absence of FUS, the expression level of 136 circRNAs
varied significantly (Supplementary Data 2). Notably, 111 out of
the 136 circRNAs were downregulated in FUS / MNs (Fig. 1d
and Supplementary Data 2). For the majority of the dysregulated
circRNAs, changes were not concordant with their linear
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Figure 1 | mESC in vitro differentiation to spinal motor neurons and RNA-seq analysis. (a) Schematic overview of the murine motor neuron
differentiation protocol and of the RNA-seq analysis. The procedures are reported in Supplementary Fig. 1a and in Methods section. (b) Pie chart showing
the number of circRNAs hosted by protein-coding, non-coding genes and intergenic regions (No gene). (c) Venn diagram showing circRNA localization
within the body of protein-coding genes. Numbers refer to circRNA species for each category. (d) Scatter plot showing the correlation of log2 fold change
of circRNAs (x axis) and their cognate linear RNAs (y axis) in FUS / conditions. The distributions of the fold change values are shown above and aside
the scatter plot. Turquoise dots indicate when only circRNA species are altered in FUS / ; magenta dots indicate when only linear RNAs are deregulated;
circRNA and linear counterparts either deregulated or unaffected are indicated by orange and black dots, respectively.
Table 1 | Summary of RNA-seq results for six different samples.
Genotype FUSþ /þ FUS /
Samples Replicate 1 Replicate 2 Replicate 3 Replicate 1 Replicate 2 Replicate 3
Raw read pairs 44,248,846 41,761,535 54,227,816 42,627,671 42,543,241 57,617,180
Read pairs after preprocessing 42,373,468 39,810,100 52,093,794 40,626,338 39,716,300 55,182,405
Read pairs after abundant transcript filtering 38,203,006 34,387,987 46,426,839 36,306,476 35,475,603 49,580,705
Reads not mapping linearly to genome 14,212,137 13,267,421 17,151,574 14,354,276 13,429,149 17,228,985
Back-splicing reads unfiltered 30,153 30,408 35,905 27,006 25,867 32,829
Linear splicing reads unfiltered 8,325,574 7,776,167 10,075,345 8,458,768 7,954,743 10,095,981
Back-splicing reads 15,303 18,064 19,548 14,704 13,854 16,584
Linear splicing reads 8,249,195 7,704,546 9,984,445 8,384,786 7,882,403 10,005,241
Back-splicing junctions 6,687 7,345 7,793 6,413 6,100 6,943
Linear splicing junctions 183,464 175,357 189,769 186,635 182,302 193,240
Circular RNAs, minimum two reads 1,299 1,675 1,624 1,280 1,235 1,399
Total circular RNAs 4,076
Total circular RNAs not spanning multiple loci 3,980
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counterpart, with only two of them significantly paralleling the
behaviour of the host linear transcript (Fig. 1d and Supplementary
Data 2). As circRNA dysregulation in these two cases could be due
to transcriptional regulation of the host gene and not to a post-
transcriptional event, these two circRNAs were excluded from
further analysis.
Focussing on the 134 circRNAs that appeared to be regulated
at the post-transcriptional level, we applied several criteria to
restrict the number of species for a more refined molecular
analysis. We selected circRNAs having at least two reads
on average among all six samples sequenced, dysregulation of
log2 fold change 40.4 and localization in host genes with
a known or potential role in neuronal physiology. This filtering
allowed the selection of 21 circRNAs (Table 2) whose circularity
was verified by RNaseR resistance (Supplementary Fig. 2a,b).
C-76 and c-77 showed high sensitivity to RNaseR and therefore
they were not considered for further analysis. For almost
every circRNA, reverse transcription–PCR (RT–PCR) produced
a band of the expected size in addition to longer products,
possibly corresponding to concatemers, generated by rolling
circle retro-transcription5. For two circRNAs, c-01 and c-87,
short and long products were gel purified and sequenced,
confirming that indeed they were back-splicing products and
concatemers, respectively (Supplementary Fig. 2c,d). The
expression of the 19 validated circRNA species was then
measured by quantitative RT–PCR in GFPþ -FUSþ /þ and
GFPþ -FUS / MNs and all of them resulted significantly
deregulated, in agreement with RNA-seq: in FUS / conditions,
14 were downregulated and 5 upregulated (Fig. 2a). The
modulation of the corresponding linear transcripts was also
measured in FUS / versus FUSþ /þ conditions, and in all
cases no significant variations were observed, indicating that
the altered levels of the circular molecules were not due to
transcriptional changes (Supplementary Fig. 2e).
In order to address the MN specificity of these species,
we compared their levels in undifferentiated FUSþ /þ mESCs
and in differentiated GFP -FUSþ /þ and GFPþ -FUSþ /þ cells
(Fig. 2b). The data indicate that several circRNAs are expressed
already in proliferating mESCs, while others are upregulated
during differentiation with nine species enriched in GFPþ MNs
(c-1, c-2, c-13, c-16, c-48, c-80, c-82, c-84 and c-88). Northern
blot was also used as a means to analyse circRNA expression; for
two abundant species, c-31 and c-78, the upregulation upon
differentiation and the differential expression levels in FUSþ /þ
versus FUS / MNs were confirmed (Fig. 2c).
Analysis of the expression of the linear counterparts during
differentiation indicated that most of them showed a similar
variation to the circular molecules. However, in the case of c-16
and c-79 an inverse correlation was found, with the linear forms
(l–16 and l–79) being highly expressed in mESCs and down-
regulated upon differentiation (Supplementary Fig. 2f).
To determine whether the expression of these selected
circRNAs is conserved in human MNs, we generated MNs from
a FUSþ /þ iPSC line34 containing the HB9::GFP reporter41.
GFPþ cells were isolated from a mixed population and analysed
for the expression of MN-specific markers. These cells, while
having undetectable amounts of the NANOG pluripotency
marker, exhibited high expression levels of HB9, ISLET1 and
CHAT, consistent with their MN identity (Supplementary
Fig. 2g). For each circRNA, divergent oligonucleotide pairs were
designed on the human exons corresponding to those involved
in the back-splicing events identified in mouse. Seventeen out
of the 19 species were also detected in humans with some of
them showing specific enrichment in the GFPþ MN-enriched
fraction (Supplementary Fig. 2h).
FUS depletion and mutation affect the biogenesis of circRNAs.
To further analyse the FUS dependence of circRNA biogenesis,
we investigated in the Neuro-2a (N2a) cell line the modulation of
the 19 validated circRNAs in response to FUS downregulation or
overexpression. N2a cells are neural crest-derived neuroblasts
that respond quickly to serum deprivation and other stimuli
(for example, retinoic acid (RA)) by expressing genes that lead to
neuronal differentiation and neurite outgrowth42,43. All but one
Table 2 | List of circRNAs analysed and their linear counterparts.
Name ID Coordinates (GRCm38) Host gene
name
CircRNAs Linear RNAs
c.p.m. in
FUSþ /þ
c.p.m. in
FUS /
Fold
change
P
value
c.p.m. in
FUSþ /þ
c.p.m. in
FUS /
Fold
change
P
value
c-01 circ_3279 1:8960459889634294 Agap1 6.871 1.485  2.163 0.008 101.960 95.095 0.096 0.564
c-02 circ_1223 13:59454535 59546383 Agtpbp1 7.343 1.902  1.884 0.010
c-03 circ_5846 8:122908668 122916045 Ankrd11 10.720 4.836  1.086 0.066 115.098 135.393 0.232 0.129
c-13 circ_0273 10:93221587 93239043 Cdk17 8.540 1.258  2.500 0.001 148.740 153.840 0.043 0.807
c-16 circ_5906 8:36937560 36938758 Dlc1 58.000 87.875 0.592 0.009 377.461 397.579 0.075 0.591
c-27 circ_1165 13:36232122 36246494 Fars2 6.709 1.258  2.178 0.014 40.650 43.657 0.110 0.647
c-31 circ_5722 7:81893799 81905636 Hdgfrp3 89.831 53.936 0.741 0.002 315.508 323.305 0.035 0.743
c-45 circ_5313 6:5100432 5115480 Ppp1r9a 5.818 1.774  1.592 0.051 57.456 58.201 0.012 0.952
c-48 circ_1733 15:39566943 39616510 Rims2 69.158 32.256  1.091 0.000 83.871 67.287 0.322 0.075
c-52 circ_5622 7:4659060746635556 Sergef 8.549 1.387  2.458 0.004 43.857 45.445 0.071 0.763
c-75 circ_0907 12:51621780 51661713 Strn3 17.591 4.744  1.896 0.000 123.639 119.365 0.044 0.756
c-76 circ_0919 12:52516079 52519967 Arhgap5 91.143 55.960 0.700 0.006 61.603 68.884 0.163 0.318
c-77 circ_0920 12:52516079 52542636 Arhgap5 19.451 10.481 0.870 0.026 37.840 46.675 0.312 0.126
c-78 circ_2111 16:9438391294393174 Ttc3 83.164 26.259  1.684 0.000 163.366 201.963 0.309 0.023
c-79 circ_2193 17:26736789 26743131 Crebrf 9.619 3.646  1.385 0.019 14.501 21.935 0.582 0.074
c-80 circ_4484 4:4860458148617331 Tmeff1 96.109 43.729  1.128 0.000 1,284.342 1,193.313 0.107 0.316
c-82 circ_3217 1:64078707 64079334 Klf7 1.745 8.033 2.029 0.005 134.317 135.387 0.012 0.944
c-83 circ_3834 2:74568941 74573626 Lnp 16.414 30.085 0.836 0.026 157.845 158.449 0.007 0.962
c-84 circ_2254 17:4303759543040189 Tnfrsf21 1.011 4.259 2.006 0.037 89.263 105.678 0.242 0.160
c-87 circ_5306 6:4757656347577667 Ezh2 21.829 35.535 0.721 0.043 26.833 22.479 0.260 0.282
c-88 circ_1224 13:59460469 59462173 Agtpbp1 0.467 3.547 2.628 0.012 161.150 166.469 0.045 0.772
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circRNAs were found to be expressed in this cell line
(Supplementary Fig. 3a). Nuclear/cytoplasmic fractionation of
N2a cells demonstrated that 15 out of the 18 circular species
were mainly localized in the cytoplasm, whereas the others
(c-01, c-87 and c-88) had an almost exclusive nuclear localization
(Supplementary Fig. 3b). Notably, sequencing of the nuclear
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Figure 2 | CircRNA expression upon FUS depletion and in MN differentiation of mESCs. (a) circRNA expression analysed by qRT–PCR in sorted
GFPþ -FUSþ /þ and GFPþ -FUS / cells. The 14 downregulated (left) and 5 upregulated (right) species are reported. CircRNA levels were normalized
against Atp5o mRNA levels and expressed as relative quantity with respect to the GFPþ -FUSþ /þ sample set to a value of 1. (b) The histogram shows the
expression level of circRNAs, measured by qRT–PCR, in FUSþ /þ mESCs and GFPþ -FUSþ /þ and GFP -FUSþ /þ cells. Their values were normalized
against Atp5o mRNA levels and expressed as relative quantity with respect to GFP samples set to a value of 1. For a,b, error bars represent s.e.m. of three
independent experiments. *Po0.05, **Po0.01 and ***Po0.001 correspond to two-tailed Student’s t-test. (c) Left panel: location on the circRNA of the
DIG-labelled probe used for northern blot analysis. Right panel: Northern blots on 10 mg of total RNA from FUSþ /þ mESCs, GFP -FUSþ /þ ,
GFPþ -FUSþ /þ and GFPþ -FUS / cells. The circular forms are indicated aside the gels; asterisks indicate two additional bands likely corresponding to
the two alternative linear forms of the c-31 host mRNAs (Hdgfrp3-001, ENSMUST00000107305.7, 5,887 nt; Hdgfrp3-002, ENSMUST00000026094.5,
2,865 nt). Each blot is shown in parallel to the EtBr staining of the agarose gel, where the migration of the 18S and 28S rRNAs is indicated.
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species indicated the absence of intron sequences (Supplementary
Fig. 2c,d); therefore, these circRNAs represent the first examples
of completely spliced nuclear circRNAs13.
We then tested the circRNA expression in differentiated
N2a cells that were treated with siRNAs targeting the murine
FUS (Fig. 3a,b). For 14 circRNAs, we observed a modulation
concordant with that observed in GFPþ -FUS / MNs (Fig. 2a).
In particular, 11 species were downregulated by FUS depletion,
while 3 were upregulated (Fig. 3b). Notably, in no case
concordant variation of the linear transcripts was observed,
confirming that alteration of circRNAs was not due to effects on
transcription (Supplementary Fig. 3c).
In the same system, we then analysed the effects of FUS rescue
on circRNA production. N2a clones carrying Doxycycline
(Dox)-inducible expression cassette for cDNAs encoding the
human WT or the ALS-linked FUSR521C and FUSP525L mutant
proteins were treated with siRNAs, unable to target the transgene,
and subsequently with Dox. Comparable levels of exogenous
FUS proteins were induced in the mutant clones with respect to
the FUSWT (Fig. 3a and Supplementary Fig. 3d). Relative
to FUSWT, the FUSR521C and FUSP525L proteins were previously
shown to decrease in the nuclear compartment and to be
mislocalized to the cytoplasm, more so in the case of FUSP525L
(refs 44,45). With respect to a control cell line carrying an empty
vector (Ctrl), the ectopic expression of FUSWT was able to rescue
the correct expression levels of almost all circRNAs (Fig. 3c). For
those species that were downregulated in FUS RNAi, FUSR521C
and FUSP525L failed to fully rescue circRNA levels with the
strongest effect observed with FUSP525L, the more mislocalized of
the two mutant FUS proteins. Even if a simple hypothesis would
correlate this phenotype with the amount of nuclear FUS, it
cannot be excluded that the mutations per se lead to a loss of
activity in splicing regulation; in fact, it was previously shown that
both the FUSR521C and FUSP525L lead to decreased interactions
with splicing promoting factors, such as the U1-70K (ref. 31).
Therefore, by losing such interaction the mutant proteins could
affect the proper utilization of specific splice junctions more
sensitive to U1 snRNP recognition.
For the circRNAs upregulated upon FUS depletion, the
FUSR521C and FUSP525L proteins were able to reduce circRNAs
at the same levels as FUSWT. These results can indicate that either
low levels of nuclear FUS are sufficient to inhibit circularization
or, alternatively, since both mutants were shown to have a higher
binding affinity than the WT protein to the splicing-related factor
SMN31,46, they could act as stronger splicing inhibitors.
Therefore, through loss or gain of function, mutant FUS
proteins can exert different role in splicing and back-splicing
regulation depending on the protein–protein and RNA–protein
complexes involved.
In order to test whether the FUS-dependent circRNA
biogenesis observed in mouse is conserved in human, we
analysed RNA from human iPSC-derived MNs carrying the
P525L mutation either in heterozygous or homozygous form
(FUSWT/P525L and FUSP525L/P525L)34. Notably, two circRNAs
downregulated upon FUS depletion were also downregulated in
FUSP525L/P525L MNs, with no effect in the heterozygous (Fig. 3d).
This very likely correlates with the fact that, in such experimental
systems, it is impossible to reproduce the exact timing of
FUS delocalization that occurs in ALS patients after several
decades of life.
FUS binds to circularizing exon–intron junctions. Since the
regulation of back-splicing normally involves the introns
flanking the circularized exons, we preliminary retrieved and
re-analysed public FUS CLIP-Seq data from the mouse brain47 in
search for FUS-binding sites within the 500 nt proximal to
back-splicing sites (1–500 nt regions) of the 134 circRNAs
deregulated in FUS / MNs. We considered only those
interactions where at least one CLIP-Seq peak mapped into one
of the two flanking intronic regions. We noticed that the
percentage of deregulated circRNAs that are bound by FUS (35%)
is significantly higher than that of circRNAs unaffected by the
lack of FUS (24%, P value for chi-squared test¼ 0.0208;
Supplementary Fig. 4a). This enrichment was maintained when
sequences up to 1,000 nucleotides were considered, while it was
lost when higher distances were analysed (Supplementary
Fig. 4a). These results are in agreement with the notion that the
sequences involved in the control of back-splicing are in general
in the proximal intron regions12,21,22. Notably, focussing on
the 1–500 region, the percentage of deregulated circRNAs that
are bound by FUS increases when a more stringent P value
cutoffs is used to select differentially expressed circRNAs
(0.001 or 0.005; Supplementary Fig. 4b); in other words,
FUS preferentially binds the introns of those circRNAs whose
deregulation is more robustly supported by the RNA-seq data.
We then tested more in detail FUS association with specific
circRNA precursors by CLIP analysis on differentiated N2a cells.
Nuclear extracts were subjected to FUS immunoprecipitation
(Fig. 4a) and the recovered RNA was analysed with primers
spanning the exon–intron junctions of the exons involved in the
back-splicing event (Fig. 4b, 50 and 30 primers). As control for each
precursor transcript, primers were designed on exon–intron
splice junctions of either upstream or downstream regions
at a distance of at least 10 kb (Fig. 4b, NEG primers). The
NEG primers identify transcript regions that were verified in
the RNA-seq data not to be affected by FUS levels (Suppleme-
ntary Fig. 4c). The region between exon 7 and intron 7 of
FUS pre-mRNA, known to bind FUS48,49, was used as a positive
control, while the pre-mRNA of ATP5o was used as a negative
control34 (Fig. 4c). Notably, compared to controls, circRNAs
responding to FUS depletion/overexpression exhibited enrichment
for FUS binding in at least one of the two splice junctions involved
in the back-splicing event (Fig. 4d). In conclusion, these data
indicate that FUS interacts with the pre-mRNA regions controlling
the biogenesis of specific circRNAs.
In order to finally prove the direct involvement of FUS in the
back-splicing reaction, we cloned the exon regions of c-03 and
c-87 together with B1,500 nucleotides of flanking introns
into the pcDNA 3.1þ expression vector (Fig. 5a). Transfection
in N2a cells together with scramble and FUS siRNAs indicated
that both constructs were able to produce the corresponding
circRNAs and to respond to FUS as the host endogenous
transcripts (Fig. 5b and Supplementary Fig. 5). In particular,
c-HA03 was downregulated while c-HA87 was upregulated upon
FUS depletion. These data indicate that B1,500 nucleotides are
sufficient to drive circularization and to confer FUS dependence
of the back-splicing reaction.
Discussion
The discovery that circRNAs are widely expressed and highly
conserved in all cell types has increased the potential impact of
non-coding RNAs on cell function, adding to the complexity of
regulatory processes. Moreover, in the nervous system where
alternative splicing occurs more frequently than in other tissues,
back-splicing further enlarges the number of transcript isoforms
deriving from a primary transcriptional unit. It is now clearly
established that circRNAs are not the result of splicing errors
but instead, their biogenesis depends on the concerted activity
of cis- and trans-acting factors.
In this study, we identified the RNA-binding protein FUS as
a new regulator of circRNA production and we defined its
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important role in controlling the expression of these molecules in
mouse MNs. Considering its role in splicing regulation and in
neurodegenerative disorders such as ALS and frontotemporal
dementia, the study of FUS in circRNA biogenesis is important
not only to elucidate its role in this process but also to link
circRNA function to neurodegenerative processes.
The conditions of FUS depletion, even if not directly
correlating with human mutations, represent a very suitable
model system for studying nuclear loss of function of FUS and its
impact on splicing processes.
Our data indicate that in vitro-derived MNs express a high
number of circRNAs and that a specific subclass is affected by
FUS levels. Interestingly, the observed variations in circRNA
abundance were attributed to post-transcriptional events and not
to transcriptional ones since, upon FUS depletion, the host linear
transcripts did not vary or, in a minority of cases, changed in an
opposite way with respect to the circRNA.
A more detailed analysis of a subgroup of circRNAs, validated
by quantitative RT–PCR, indicated that FUS may either
enhance or repress the back-splicing reaction. This is in line
with previous studies indicating that FUS can act both as an
activator and a repressor of splicing50,51. Notably, analysis of
subcellular localization led us to identify nuclear circRNA species
entirely derived from exonic sequences. Until now, only intron-
containing circRNAs were known to be localized in the nucleus13;
therefore, these species may represent very interesting material
for studying the function of circRNAs in this compartment.
Interestingly, our data demonstrate that circRNAs that
decrease in FUS / cells also consistently diminish in condi-
tions of FUS RNAi and inversely increase when FUS is ectopically
expressed, indicating a direct relationship between the amount of
back-splicing and the levels of FUS. CLIP experiments showed
that FUS associates with intron regions proximal to the splice
junctions involved in circRNA formation. This is in agreement
with previous work indicating that FUS binds preferentially very
long introns with preference for the 50 end of the intron47,51 and,
in particular, around the alternatively spliced exons of genes
associated with neuronal functions and neurodegeneration50.
The use of the human FUSR521C and FUSP525L mutants,
characterized by weak and strong cytoplasmic delocalization,
respectively, has allowed to integrate the knockdown conditions
(loss of function) with putative toxic gain-of-function activities
due to specific mutations52. Interestingly, ALS-causative
mutations have been shown to alter the splicing mode in
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Figure 3 | CircRNA expression upon ectopic expression of wild-type and mutant FUS. (a) Western blot analysis on total protein extracts from
differentiated N2a cells treated with control siRNAs (siScr) or with siRNAs against FUS (siFUS). In the same blot, shown also are proteins derived from
differentiated N2a cells stably transfected with an Ctrl or with FUSWT (WT), FUSR521C (R521C) and FUSP525L (P525L) cDNA expression cassettes and
treated with siFUS and Dox. GAPDH was used as a loading control. (b) Histograms show the levels of circRNAs in differentiated N2a cells treated
with control siRNAs (siScr; black bars) or with siRNAs against FUS (siFUS; grey bars). CircRNA were quantified by qRT–PCR, normalized against Atp5o
mRNA levels and expressed as relative quantity with respect to siScr samples set to a value of 1. (c) Histograms show the levels of circRNAs in the samples
treated as in a; the values were normalized against Atp5o mRNA levels and siScr samples set to a value of 1. Statistical analysis was performed on Ctrl,
FUSWT, FUSR521C and FUSP525L samples against siFUS samples. (d) Histograms show the level of hsc-80 and hsc-84 in FUSWT/WT, FUSWT/P525L
and FUSP525L/P525L iPSC-derived MNs. CircRNAs were normalized against Atp5o mRNA levels and expressed as relative quantity with respect to
FUS WT/WT samples set to a value of 1. For all the experiments shown in the figure, error bars represent s.e.m. of at least three independent experiments.
*Po0.05, **Po0.01 and ***Po0.001 correspond to two-tailed Student’s t-test.
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a positive and negative manner through the ‘gain’ and ‘loss’ of
interactions with specific splicing factors31,46. Likewise, the effects
of ‘gain’ and ‘loss’ properties of mutant FUS are expected to be
further complicated by their time-dependent progressive cytosolic
accumulation observed in patients.
When considering the role of FUS on back-splicing, it
is important to note that both decreased nuclear levels and
altered interactions of the mutant proteins may affect the
utilization of target splice junctions, thus altering the splicing
mode of specific exon–intron domains of a primary transcript.
Since FUS could also control the splicing of the host transcripts,
a complex interplay between linear and back-splicing might
be required to ensure the correct transcriptional outcome of
specific genomic loci.
Notably, most of the circRNA species altered upon FUS
depletion in murine MNs are conserved in human iPSCs-derived
MNs, indicating that the activities of this novel class of
transcripts may also be conserved. Two circRNAs appeared to
be deregulated in a FUS-dependent manner similarly to the
mouse, more directly linking circRNA production to the
ALS pathology. The fact that this effect was evident only in the
FUSP525L homozygous context is likely due to the experimental
system used which is unable to reproduce the long-term features
of ALS pathogenesis.
In conclusion, our study demonstrates that FUS regulates the
splicing of a novel and abundant class of transcripts whose
functions are still largely unknown. Moreover, we provide a novel
system to study the role of circRNA-dependent regulatory
networks in MNs, which may lead to new insights into the
mechanism of mutant FUS-associated ALS and related disorders.
Methods
Oligonucleotides. Oligonucleotide sequences used in this study are listed in
Supplementary Table 1.
Plasmid construction. Plasmids for circRNA expression were constructed using
pcDNA3.1þ backbone. To generate pc-HA03 and pc-HA87 constructs, two
regions spanning intron 1 (B1,500 nt)–exon 2 and exon 3–intron 2 (B1,500 nt)
of each corresponding host gene were PCR amplified from N2a genomic
DNA using oligonucleotides listed in Supplementary Table 1. These two
regions together with pcDNA3.1þ vector digested with HindIII-EcoRI for
c-87, and with BamhI-XhoI for c-03, were ligated together using In-Fusion
HD Cloning Kit (Clontech) according to the manufacturer’s instructions. The HA
tag was then inserted by inverted PCR using oligonucleotides listed in
Supplementary Table 1.
Cell cultures and treatments. mESCs were cultured and differentiated as
described in Wichterle et al.40. Briefly, generation of embryoid bodies (EBs)
was achieved by culturing mESCs in ADNFK medium (1:1 Advanced DMEM/
F12:Neurobasal medium, 10% Knock Out Serum Replacement (Gibco, 10828028),
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200mM L-Glutamine, 0.1mM 2-mercaptoethanol, 1 Pen/Strep). On day 2,
ADNFK medium was complemented with 1 B27 Supplement (Gibco,
17504-044), 1 mM RA (Sigma Aldrich, R2625) and 0.5 mM SAG (Merck Millipore,
566660). EBs were expanded for 2 more days in these conditions and then
disrupted by Papain dissociation system (Worthington Biochemical Corporation)
following the manufacturer’s instructions.
A specific reporter expressing myristoylated GFP under the control of the
MNs promoter Hb9 was stably integrated in the mESCs derived from either
FUSþ /þ or FUS / mice as described in Wichterle et al.40. Mature EBs were
disrupted by Papain dissociation system (Worthington Biochemical Corporation)
following the manufacturer’s instructions. Hb9-GFP expressing cells were sorted
in PBS using MoFlo Astrios cell sorter (Beckman Counter) configured with
a 100 mm ceramic nozzle and operating at 28 psi. Purified GFPþ cells were
collected by centrifugation and RNA was extracted by Direct-zol RNA MiniPrep
(Zymo Research).
Culturing and differentiation of human iPSCs were performed as described
in Lenzi et al.34 with modifications. Briefly, human iPSCs were maintained in
Nutristem-XF (Biological Industries) in plates coated with hESC-qualified matrigel
(BD Biosciences) and passaged every 4–5 days with 1mgml 1 dispase (Gibco).
MNs were derived based on a previously described protocol modified to use
adherent cells53 as follows. Cells were cultured until confluent. Then the media
was changed to neuron differentiation media: DMEM/F12:neurobasal 1:1
(Life Technologies) supplemented with nonessential amino acids, glutamax,
B27 and N2 (Life Technologies). From day 0 to day 6, neuron differentiation
media was supplemented with 1 mM RA (Sigma Aldrich), 1 mM smoothened
agonist (Calbiochem), 0.1 mM LDN-193189 (Miltenyi Biotec) and 10 mM
SB-431542 (Miltenyi Biotec). From day 7 to day 14, neuron differentiation
media was supplemented with 1 mM RA, 1 mM smoothened agonist, 4 mM
SU-5402 (Sigma Aldrich) and 5 mM DAPT (Sigma Aldrich).
A specific reporter expressing myristoylated GFP under the control of the
MN promoter HB9 was stably integrated in the FUSwt/wt, FUSP525L/P525L and
FUSWT/P525L iPSCs cell line as described in Wainger et al.41. Briefly, this reporter
system is based on a HB9::GFP cassette embedded in a donor plasmid containing
homology arms specific for the AAVS1 locus and a Puromycin resistance gene.
This plasmid was co-transfected in iPSCs with AAVS1 ZFN (Sigma) with the
Neon Transfection System (Life Technologies) as described in Lenzi et al.34,
and stable transfectants were isolated by Puromycin selection. Upon cell
differentiation, iPSC-derived human MNs were dissociated and single-cell
suspension were prepared for isolation. MNs were sorted based on GFP expression
using a FACSAriaIII (Becton Dickinson, BD Biosciences) configured with a 100 mm
ceramic nozzle and operating at 19.84 psi. FACSAriaIII is equipped with a 488 nm
laser and with the FACSDiva software (BD Biosciences version 6.1.3). Data were
analysed using the FlowJo software (Tree Star). Following isolation, an aliquot of
each tube of the sorted cells was evaluated for purity at the same sorter resulting in
an enrichment 498–99% for each sample. Purified GFPþ cells were collected
by centrifugation and plated on laminin-coated plates. After 7 days post-sorting,
RNA was extracted by Direct-zol RNA MiniPrep (Zymo Research).
N2a cells, from ATCC (Cat. No. CCL-131), were cultured in DMEM
medium D6546 (Sigma-Aldrich) supplemented with 10% fetal bovine serum
(F7524, Sigma-Aldrich), L-glutamine (G7513, Sigma-Aldrich) and Penicillin–
Streptomycin (P0781, Sigma-Aldrich). Differentiation was induced on
70% confluent plates with serum deprivation to a final concentration of 2% and
20 mM RA (R2625, Sigma-Aldrich).
SiRNA against FUS (50-GAGTGGAGGTTATGGTCAA-30)50 and siScr
(AllStars Neg. Control siRNA, 1027281, Qiagen) were transfected using
Lipofectamine RNAiMAX Reagent (Thermo Fisher Scientific) according to the
manufacturer’s instructions.
For the generation of stable N2a cells expressing human FUS protein, the Flag-
FUSWT, Flag-FUSR521C and Flag-FUSP525LepB-Puro-TT-derived plasmids45 and
epiggyBac transposase vector were transfected using Lipofectamine and Plus
Reagent (Thermo Fisher Scientific). After 72 h, the cells were selected with
Puromycin (1mgml 1) treatment and the expression of the different forms of
FUS protein was induced by adding Dox (0.2 mgml 1) to the culture medium 48 h
before collecting the cells.
Nuclear/cytoplasmic fractionation was carried out by using the PARIS Kit
(Ambion) on differentiated N2a cells following the manufacturer’s specifications.
Bioinformatic analysis. Total RNA was extracted from sorted Hb9::GFPþ
FUSþ /þ and FUS / cells and sequenced on a Illumina Hiseq 2,500 Sequencing
system using TruSeq Stranded Total RNA Library Prep Kit with Ribo-Zero
treatment (Illumina). An average of about 47 million 100 base pairs long paired-
end reads were produced for each sample.
RNA-Seq reads were initially trimmed using the Trimmomatic software54 to
remove adapter sequences and poor quality bases. After that, Bowtie 2 (ref. 55) was
used to align reads to a sequence database composed of rRNA, tRNA, snRNA,
snoRNA and other non-coding species, which resulted to be overrepresented
according to the FastQC software56; reads mapping linearly to these sequences
were filtered out. The remaining reads were used for circRNA detection as follows:
the two mates of each pair of reads (R1 and R2) were aligned separately to the
reference genome (Bowtie 2 to GRCm38) and those mapping were discarded;
the rest was used as input for find_circ10. First, 20 nt long anchors were produced
from the ends of each read, then anchors were aligned to the reference genome
with Bowtie 2 and alignments of both R1- and R2-derived anchors were used
by find_circ to identify and count circular and linear splicing events, restricted
by the presence of a GU/AG signal. Circular splicing events were then filtered
for each biological sample separately for a few parameters, including: at least two
unique reads mapping to head-to-tail junctions, distance between mapped anchors
o100 kb, and mapping quality of the anchors of at least 35. Filtered circRNAs
from each sample were then merged and, for all of them, reads mapping linearly to
each of the two coordinates of the head-to-tail splice junction were parsed from the
find_circ output and counted. We further excluded those putative back-splicing
events that were spanning two non-overlapping genes, which were likely to be due
to mapping errors.
To evaluate the differential expression of circRNAs between FUSþ /þ and
FUS / conditions, we provided the edgeR software57 with the read counts of
both the back-splicing events and their cognate linear splicing events; the read
counts of cognate linear splicing events were calculated summing all the reads
mapping linearly on both the splice junctions involved in back-splicing. Events not
having two or more reads in at least three samples were not tested for differential
expression. Model fitting and testing was performed using the glmFIT and glmLRT
functions. Given the low number of reads used for testing, we decided to use
P value instead of false discovery rate to select for differentially expressed events,
setting the significance threshold value to 0.05.
The BEDTools software suite58 was employed to annotate circRNAs by
intersecting their genomic coordinates with those of the genomic features described
in the Ensembl 77 gene annotation59.
The comparison of the observed and the expected localization of circRNAs
within the body of protein-coding transcripts was done as follows: circRNAs whose
back-splicing junctions fall in an intron or outside the gene were filtered out; we
then computed the distribution of the number of exons included between each
circRNA back-splicing junction pair (for those cases in which the exonic structure
of circRNAs could not be defined unambiguously due to the alternative splicing of
the gene, we used the average number of exons rounded to the nearest integer);
from the transcripts hosting these circRNAs, we randomly picked 5,000 groups of
consecutive internal exons (used to simulate faux circRNAs), the number of exons
of each group being sampled from the distribution of the number of exons
previously computed; the localization of real and faux circRNAs with respect to
untranslated regions and coding regions was determined; a chi-squared test was
performed to determine whether real circRNAs show a preferential localization
when compared to random faux circRNAs.
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Figure 5 | Artificial constructs reproduce FUS-dependent back-splicing.
(a) Schematic representation of the pc-HA-c03 and pc-HA-c87 constructs.
The second and third exons were cloned into pc-DNA3.1þ vector together
withB1,500 nucleotides of the flanking introns. An HA tag was inserted in
order to discriminate the ectopically expressed circRNAs from the
endogenous ones. (b) Histograms show the circRNA levels derived from
pc-HA03 and pc-HA87 together with the corresponding linear transcripts
(pre-c-HA03 and pre-c-HA87) in N2a cells treated with control siRNAs
(siScr; black bars) or with siRNAs against FUS (siFUS; grey bars). The
values were normalized against Neomycin mRNA levels and expressed as
relative quantity with respect to siScr samples set to a value of 1. For all the
experiments shown in the figure, error bars represent s.e.m. of three
independent experiments. *Po0.05 corresponds to two-tailed Student’s
t-test.
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Raw reads from FUS HITS-CLIP experiment conducted by Lagier-Tourenne
et al.47 on whole mouse brain were downloaded from Gene Epression Omnibus.
We identified FUS CLIP-Seq peaks for each of the three biological replicates
separately. First, adapter and quality trimming of reads was performed using
Trimmomatic; Cutadapt60 was then used to remove all the adapter sequences that
were not trimmed in the first phase. Trimmed reads were aligned to GRCm38
using Bowtie61 with parameters -a -m 1 --best --strata. Duplicate reads, which
could represent PCR artifacts, were removed using MarkDuplicates from Picard
(picard.sourceforge.net/command-line-overview.shtml). Tools from the Pyicoteo62
suite were used to call CLIP-Seq peaks. First, all reads were extended to a length of
36 nucleotides using the pyicos extend tool. Then, CLIP-Seq peak calling was
performed using the pyicoclip tool. Ensembl 77 GTF file was supplied to generate
exploratory regions, using the option --region-magic genebody. For each replicate,
only peaks with P value o0.0001 were retained. Finally, BEDTools merge with
option -d 50 was used to merge peaks from all the replicates; all those peaks that
resulted from the merge of peaks identified in at least two replicates were taken as
FUS-binding sites. The two circRNAs whose deregulation parallels that of the
linear counterpart were excluded from the analysis. The list of robustly expressed
circRNAs was further reduced by removing all those circRNAs with back-splicing
sites that did not coincide with annotated splice sites; this way, 1,026 out of the
1,151 circRNAs were retained. We also filtered out all the circRNAs that are
flanked by introns shorter than 1,500 nt, narrowing the list down to 938 circRNAs.
BEDTools intersect was used to find all the FUS-binding sites falling in the intronic
regions flanking circRNA back-splicing sites.
Protein extraction and western blot. Whole-cell protein extracts were
prepared from N2a cells using RIPA buffer and subjected to western blot
analysis performed using precasted NuPAGE SDS-PAGE gels and reagents from
Invitrogen. The immunoblots were incubated with the following antibodies
diluted in 5% skim milk in TBS-T: FUS/TLS (sc-47711, Santa Cruz, 1:2,000),
GAPDH (sc-32233, Santa Cruz, 1:2,000), SUZ12 (SC-46264, Santa Cruz, 1:200),
and TBP (sc-273, Santa Cruz, 1:200). All the images were captured using the
Molecular Imager ChemiDoc XRSþ (Bio-Rad), and the densitometric analyses
were performed using the associated Image Lab software (Bio-Rad). Full scan
of western blots are presented in Supplementary Fig. 7.
RNA preparation and analysis. Total RNA and RNA from nuclear/cytoplasmic
fractionations was isolated using the Direct-zol RNA MiniPrep Kit with on-column
DNAse treatment, according to the manufacturer’s instructions (Zymo Research).
RNaseR treatment was performed on total RNA extracted from mouse
EBs at day 6 of differentiation; 6U of RNaseR (RNR07250, Epicentre) was used
for 1 mg of RNA and the reaction was carried out for 150 at 37 C; the RNA was
then extracted using the Direct-zol RNA MiniPrep Kit (Zymo Research).
For RNA retro-transcription, the SuperScript VILO cDNA Synthesis Kit was
used (Thermo Fisher Scientific).
For the detection of circRNAs and their linear counterparts, cDNA samples
were analysed by quantitative real-time PCR using PowerUp SYBR Green Master
Mix (Thermo Fisher Scientific).
For the RNA extracted in CLIP experiments, semi-quantitative PCR was
performed on cDNAs using MyTaq Red DNA Polymerase (Bioline) according to
the manufacturer’s instructions. The samples were then loaded on a 2.5% agarose
gel. All the images were captured using the Molecular Imager ChemiDoc
XRSþ (Bio-Rad), and the densitometric analyses were performed using the
associated Image Lab software (Bio-Rad).
The oligonucleotides used in all the amplification steps are listed in
Supplementary Table 1.
Northern blot. In all, 10 mg of total RNA from mESCs, GFP FUSþ /þ ,
GFPþFUSþ /þ and was GFPþFUS / were denatured with one volume of
glyoxal loading dye (Ambion) for 300 at 50 C and loaded on 1.2% agarose gel.
Electrophoresis was carried out for 2 h at 60V. RNA was transferred on Hybond
Nþ membrane (GE Healthcare) by capillarity overnight in 10 SSC. Transferred
RNA was cross-linked with UV at 1,200 100mJ cm 2 and the membrane
was washed in 50mM Tris pH 8.0 for 20min at 45 C. Prehybridization and
hybridization were performed in NorthernMax buffer (Ambion) at 68 C
(30min and overnight, respectively). A total of 500 ng of DIG-labelled probe
in 10ml were used for hybridization. The membrane was then washed with
2 SSC 0.1% SDS twice 30min, then once 30min and once 1 h with
0.2 SSC 0.1% SDS at hybridization temperature. The membrane was the
processed for DIG detection (hybridization with anti-DIG antibody, washing
and luminescence detection) with the DIG Luminescence Detection Kit (Roche),
according to the manufacturer’s instructions. DIG-labelled probes were produced
by in vitro transcription with DIG-RNA labelling mix (Roche) of PCR templates
produced with the oligonucleotides listed in Supplementary Table 1. Transcription
with T7 RNA polymerase (Promega) was carried out for 2 h and the RNA was
then resolved and purified by electrophoresis on denaturing polyacrylamide gel.
Full scan of northern blots are presented in Supplementary Fig. 6.
Nuclear cross-linking and immunoprecipitation assay. Plates (10 10 cm2)
of 20% confluent differentiated N2a cells were UV cross-linked at
4,000 100mJ cm 2 energy. Cells were resuspended in nuclear isolation
buffer (the final concentration of the buffer is: 256mM sucrose; 8mM Tris-HCl
pH 7.5; 4mM MgCl2; 0,8% Triton X-100) and immunoprecipitation was
performed as previously described by Rinn et al.63. Cells lysate was sonicated with
Bioruptor sonication device (Diagenode) and nuclear membrane and debris were
pelleted by centrifugation at 13,000 r.p.m. for 10min at 4 C. Cell lysates were
precleared with Protein G Agarose/Salmon Sperm DNA (16–201, Merck Millipore)
before incubation with either FUS Antibody (sc-47711, Santa Cruz) or mouse
IgG (sc-2025, Santa Cruz). Four washes were performed with RIP buffer
(150mM KCl, 25mM Tris pH 7.4, 5mM EDTA, 0.5mM DTT, 0.5% NP40) and
two washes with RIP High-Salt buffer (500mM KCl, 25mM Tris pH 7.4, 5mM
EDTA, 0.5mM DTT, 0.5% NP40). Before RNA extraction, 1/5 of the cell lysate
was used for western blot analysis. RNA fraction was treated with Proteinase K
(AM2546, Thermo Fisher Scientific) at 45 C for 50min; the samples were then
placed 10min at 95 C and finally the RNA was extracted using miRNeasy Mini
Kit with on-column DNAse treatment, according to the manufacturer’s
instructions (Qiagen).
Data availability. RNA sequencing raw data have been deposited at Gene
Expression Omnibus (GSE83226).
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